Up-regulation of DDX39 in human pancreatic cancer cells with acquired gemcitabine resistance compared to gemcitabine-sensitive parental cells

Anticancer Research

Volumn 33, Issue 8, 2013, Pages 3133-3136

  Kuramitsu, Yasuhiro ^a   Suenaga, Shigeyuki ^a   Wang, Yufeng ^a   Tokuda, Kazuhiro ^a   Kitagawa, Takao ^a   Tanaka, Toshiyuki ^a   Akada, Junko ^a   Maehara, Shin Ichiro ^b   Maehara, Yoshihiko ^b   Nakamura, Kazuyuki ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

DDX39; Drug resistant KLM1 cells; Gemcitabine; Pancreatic cancer

Indexed keywords

ACTIN; CELL PROTEIN; DEAD BOX PROTEIN; DEAD BOX PROTEIN 39; GEMCITABINE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER RESISTANCE; CHEMOSENSITIVITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

DDX39; DRUG-RESISTANT KLM1 CELLS; GEMCITABINE; PANCREATIC CANCER;

BLOTTING, WESTERN; CELL LINE, TUMOR; DEAD-BOX RNA HELICASES; DEOXYCYTIDINE; DRUG RESISTANCE, NEOPLASM; HUMANS; PANCREATIC NEOPLASMS; UP-REGULATION;

EID: 84883294601     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Burris HA, Moore MJ III, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD and Von Hoff DD: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15: 2403-2413, 1997.
2. Shi X, Liu S, Kleeff J, Friess H and Buchler MW: Acquired resistance of pancreatic cancer cells towards 5-fluorouracil and gemcitabine is associated with altered expression of apoptosis regulating genes. Oncology 62: 354-362, 2002.
3. Mori-Iwamoto S, Kuramitsu Y, Ryozawa S, Mikuriya K, Fujimoto M, Maehara S, Maehara Y, Okita K, Nakamura K and Sakaida I: Proteomics finding heat-shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine. Int J Oncol 31: 1345-1350, 2007.
4. Kuramitsu Y, Taba K, Ryozawa S, Yoshida K, Tanaka T, Zhang X, Maehara S, Maehara Y, Sakaida I and Nakamura K: Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry. Anticancer Res 30: 3367-3372, 2010.
5. Sugiura T, Sakurai K and Nagano Y: Intracellular characterization of DDX39, a novel growth-associated RNA helicase. Exp Cell Res 313: 782-790, 2007.
6. Cruz J, Kressler D and Linder P: Unwinding RNA in Saccharomyces cerevisiae: DEAD-box proteins and related families. Trends Biochem Sci 24: 192-198, 1999.
7. Rocak S and Linder P: DEAD-box proteins: The driving forces behind RNA metabolism. Nat Rev Mol Cell Biol 5: 232-241, 2004.
8. Yoo HN and Chung IK: Requirement of DDX39 DEAD-box RNA helicase for genome integrity and telomere protection. Aging Cell 10: 557-571, 2011.
9. Kikuta K, Kubota D, Saito T, Orita H, Yoshida A, Tsuda H, Suehara Y, Katai H, Shimada Y, Toyama Y, Sato K, Yao T, Kaneko K, Beppu Y, Murakami Y, Kawai A and Kondo T: Clinical proteomics identified ATP-dependent RNA helicase DDX39 as a novel biomarker to predict poor prognosis of patients with gastrointestinal stromal tumor. J Proteomics 75: 1089-1098. 2012.
10. Kato M, Wei M, Yamano S, Kakehashi A, Tamada S, Nakatani T and Wanibuchi H: DDX39 acts as a suppressor of invasion for bladder cancer. Cancer Sci 103: 1363-1369, 2012.
11. Kuramitsu Y, Tominaga W, Baron B, Tokuda K, Wang Y, Kitagawa T and Nakamura K: Up-regulation of DDX39 in human malignant pleural mesothelioma cell lines compared to normal pleural mesothelial cells. Anticancer Res (in press).
12. Maehara S, Tanaka S, Shimada M, Shirabe K, Saito Y, Takahashi K and Maehara Y: Selenoprotein P, as a predictor for evaluating gemcitabine resistance in human pancreatic cancer cells. Int J Cancer 112: 184-189, 2004.
13. Tanaka T, Kuramitsu Y, Fujimoto M, Naito S, Oka M and Nakamura K: Down-regulation of two isoforms of ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCH-L1) correlates with high metastatic potentials of human SN12C renal cell carcinoma cell clones. Electrophoresis 29: 2651-2659, 2008.
14. Mori-Iwamoto S, Kuramitsu Y, Ryozawa S, Taba K, Fujimoto M, Okita K, Nakamura K and Sakaida I: A proteomic profiling of gemcitabine resistance in pancreatic cancer cell lines. Mol Med Rep 1: 429-434, 2008.
15. Kuramitsu Y, Baron B, Yoshino S, Zhang X, Tanaka T, Yashiro M, Hirakawa K, Oka M and Nakamura K: Proteomic differential display analysis shows up-regulation of 14-3-3 protein sigma in human scirrhous-type gastric carcinoma cells. Anticancer Res 30: 4459-4465, 2010.
16. Kuramitsu Y, Hayashi E, Okada F, Tanaka T, Zhang X, Ueyama Y and Nakamura K: Proteomic analysis for nuclear proteins related to tumour malignant progression: A comparative proteomic study between malignant progressive cells and regressive cells. Anticancer Res 30: 2093-2099, 2010.
17. Kuramitsu Y, Takashima M, Yokoyama Y, Iizuka N, Tamesa T, Akad JK, Wang Y, Toda T, Sakaida I, Okita K, Oka M and Nakamura K: Up-regulation of kDa tubulin alpha-6 chain fragment in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus. Anticancer Res 31: 3331-3336, 2011.
18. Kubota D, Okubo T, Saito T, Suehara Y, Yoshida A, Kikuta K, Tsuda H, Katai H, Shimada Y, Kaneko K, Kawai A and Kondo T: Validation study on pfetin and ATP-dependent RNA helicase DDX39 as prognostic biomarkers in gastrointestinal stromal tumour. Jap J Clin Oncol 42: 730-741, 2012.